# Mitchell C. Benson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mitchell-c-benson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,534 |
| Field | Prostate Cancer Diagnosis and Treatment |
| h-index | 63 |
| i10-index | 195 |
| Last Known Institution | Columbia University |
| OpenAlex ID | https://openalex.org/A5011642832 |
| ORCID iD | 0000-0003-4018-5970 |
| Works | 412 |

## Researcher papers

- [Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer](https://scholariq.org/papers/docetaxel-and-estramustine-compared-with-mitoxantrone-and-prednisone-for/)
- [Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer](https://scholariq.org/papers/tumor-evolution-and-drug-response-in-patient-derived-organoid-models-of-bladder/)
- [Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer](https://scholariq.org/papers/prostate-specific-antigen-density-a-means-of-distinguishing-benign-prostatic/)
- [The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific Antigen](https://scholariq.org/papers/the-use-of-prostate-specific-antigen-density-to-enhance-the-predictive-value-of/)
- [Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.](https://scholariq.org/papers/detection-of-the-apoptosis-suppressing-oncoprotein-bc1-2-in-hormone-refractory/)
- [Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells](https://scholariq.org/papers/suppression-of-acquired-docetaxel-resistance-in-prostate-cancer-through/)
- [Single luminal epithelial progenitors can generate prostate organoids in culture](https://scholariq.org/papers/single-luminal-epithelial-progenitors-can-generate-prostate-organoids-in-culture/)
- [Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer](https://scholariq.org/papers/phase-i-trial-of-docetaxel-with-estramustine-in-androgen-independent-prostate/)
- [Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay](https://scholariq.org/papers/molecular-staging-of-prostate-cancer-with-the-use-of-an-enhanced-reverse/)
- [Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16](https://scholariq.org/papers/evaluation-of-prostate-specific-antigen-declines-for-surrogacy-in-patients/)
- [Validating the Use of the Mimic dV-trainer for Robotic Surgery Skill Acquisition Among Urology Residents](https://scholariq.org/papers/validating-the-use-of-the-mimic-dv-trainer-for-robotic-surgery-skill-acquisition/)

## Researcher topics

- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Columbia University](https://scholariq.org/institutions/columbia-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.